There is currently any group buy running for any of these drugs discussed in the first page?
I have not read the whole thread, but the first page seems very interesting! According to the effects described I found Mi-4 and anavex 1-41 something I am interested to try.
Also Kor antagonists are pretty interesting for anxiety and depression as you probably discussed already. There is an effort for a group buy.
http://www.longecity...or-a-group-buy/
Below is advertisement from Team TLR really, but from previous research I am pretty sure there are big potentials for Kor antagonists investigated currently.
Theories Behind KOR Antagonist Treatment and KORX-OX
KORX-OX as a long-acting KOR antagonist activity, in similar fashion to JDTic and other long-acting KOR antagonists, is theorized to alleviate psychoneurodysfunctional [Google it] states (moderate to severe), within a broad range of conditions, including states that encompass depression states, anxiety/fear/trauma states, OCD-S states, addiction states, depersonalization-related states, and other such psychoneurological/emotional states adverse to well-being.
The opioid system is the seat within the balance set within evolutionary 'design' of wellness:unwellness, and most all that is encompassed within such. Within that theory, currently proposed theory denotes the potential of direct antagonist activity upon KOR, the “seat of unwellness”, to foster a potent counter to this opioid receptor that is responsible for 'negative-state' promotion.
Antagonizing the receptor would appear to have no tolerance and addiction potential as with the induction of agonist activity of MOR, the “seat of wellness”, wherein such modalities are not viable as within bearing the intrinsic flaws of rapid tolerance and high addiction potential (among other well-known non-psychoactive adverse effects).
Quite to the contrary, KOR antagonist activity is anti-tolerance and anti-addiction, providing 'resetting' of “emotional tone” primarily through resetting of these pathways; within markedly reversing dysregulation within dopaminergic pathways and other addiction-related/tolerance-related pathways.
“Emotional Tone” or “Psychoneurofunctional Tone” is the level of resistance to adverse/dysfunctional emotional states (psychoneurodysfunctional states, which as well encompasses addiction states). KORX-OX in in vivo animal research has demonstrated long-acting effects (naturally tapering of effects appear to remain for 1-3 weeks after cessation of KORX-OX depending on the dose and duration of administration) within its KOR antagonist activity.
To have capacity to so profoundly improve core(KOR) tone would appear to be of greatest value as a base treatment for improving a plethora of psychoneurodysfunctionalities.
KORX-OX may be the breakthrough many are looking for within research of all paradigms with a strong underlying 'stress' component such as depression states, anxiety states, OCD and ASD states, addiction states, et. al.
Edited by Strangelove, 13 June 2015 - 05:08 PM.